Abstract
Background: Avascular necrosis (AVN) is a potentially serious multifactorial disease. In COVID-19 patients, AVN of many bones has been reported. Usually, the condition is linked to steroid therapy. In this case report, we describe our experience with bilateral AVN of femoral heads in an elderly patient months after being cured of COVID-19 infection without the use of steroids.
Case Presentation: A 68-year-old male was referred to the outpatient clinic of the rheumatology and rehabilitation department for progressive bilateral hip pain starting on the left side 5 months ago. An extensive review of the patient’s medical history identified documented COVID-19 infection that required hospitalization 9 months before presentation. Multiplanar MRI with fat suppression of both hips showed ill-defined areas of abnormal signal intensity affecting the left femoral head, neck and intertrochanteric regions with associated subchondral fissuring and mild joint effusion. A similar smaller area was also seen affecting the postero-superior aspect of the right femoral head.
Conclusion: AVN in COVID-19 patients can be encountered even in the absence of steroid therapy.
Graphical Abstract
[1]
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21(3): 133-46.
[http://dx.doi.org/10.1038/s41579-022-00846-2]
[http://dx.doi.org/10.1038/s41579-022-00846-2]
[2]
Afrisham R, Jadidi Y, Davoudi M, et al. Gastrointestinal, liver, pancreas, oral and psychological long-term symptoms of COVID-19 after recovery; A review. Mini Rev Med Chem 2022.
[http://dx.doi.org/10.2174/1389557523666221116154907] [PMID: 36397624]
[http://dx.doi.org/10.2174/1389557523666221116154907] [PMID: 36397624]
[3]
Mansell V, Hall Dykgraaf S, Kidd M, Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev 2022; 3(12): e849-54.
[http://dx.doi.org/10.1016/S2666-7568(22)00245-8] [PMID: 36480981]
[http://dx.doi.org/10.1016/S2666-7568(22)00245-8] [PMID: 36480981]
[4]
Wells ME, Dunn JC. Pathophysiology of avascular necrosis. Hand Clin 2022; 38(4): 367-76.
[http://dx.doi.org/10.1016/j.hcl.2022.03.011] [PMID: 36244704]
[http://dx.doi.org/10.1016/j.hcl.2022.03.011] [PMID: 36244704]
[5]
Zhang S, Wang C, Shi L, Xue Q. Beware of steroid-induced avascular necrosis of the femoral head in the treatment of COVID-19 : Experience and lessons from the SARS epidemic. Drug Des Devel Ther 2021; 15: 983-95.
[http://dx.doi.org/10.2147/DDDT.S298691] [PMID: 33692615]
[http://dx.doi.org/10.2147/DDDT.S298691] [PMID: 33692615]
[6]
Veizi E, Erdoğan Y, Sinem Sezgin B, Karaman Y, Kılıçarslan K, Fırat A. The painful joint after COVID-19 treatment: A study on joint osteonecrosis following COVID-19-related corticosteroid use. Eklem Hastalik Cerrahisi 2023; 34(1): 75-83.
[http://dx.doi.org/10.52312/jdrs.2023.895] [PMID: 36700267]
[http://dx.doi.org/10.52312/jdrs.2023.895] [PMID: 36700267]
[7]
Kamani S, Lakhwani MG, Phansopkar P. Undiagnosed bilateral avascular necrosis of the femur in a young male caused by COVID-19 steroid injections. Cureus 2022; 14(10): e29982.
[http://dx.doi.org/10.7759/cureus.29982] [PMID: 36381929]
[http://dx.doi.org/10.7759/cureus.29982] [PMID: 36381929]
[8]
Jain S, Sawant T. Osteonecrosis with concomitant bacterial osteomyelitis of both hips and a knee in a post–COVID-19 patient. JBJS Case Connect 2022; 12(1)
[http://dx.doi.org/10.2106/JBJS.CC.21.00629] [PMID: 35202008]
[http://dx.doi.org/10.2106/JBJS.CC.21.00629] [PMID: 35202008]
[9]
Ardakani MV, Parviz S, Ghadimi E, et al. Concomitant septic arthritis of the hip joint and femoral head avascular necrosis in patients with recent COVID-19 infection: A cautionary report. J Orthop Surg Res 2022; 17(1): 302.
[http://dx.doi.org/10.1186/s13018-022-03192-4] [PMID: 35668523]
[http://dx.doi.org/10.1186/s13018-022-03192-4] [PMID: 35668523]
[10]
Maharjan G, Yadav S, Yadav MK, khati N, Bhattarai HB, Joshi J. Steroid-induced avascular necrosis: A case report on a patient treated with steroid therapy for COVID-19. Ann Med Surg 2022; 80: 104226.
[http://dx.doi.org/10.1016/j.amsu.2022.104226] [PMID: 35936570]
[http://dx.doi.org/10.1016/j.amsu.2022.104226] [PMID: 35936570]
[11]
Annam P, Manda A, Myneni UK, et al. Corticosteroids induced avascular necrosis of hip, a “long COVID-19” complication: Case report. Ann Med Surg 2022; 82: 104753.
[http://dx.doi.org/10.1016/j.amsu.2022.104753] [PMID: 36168319]
[http://dx.doi.org/10.1016/j.amsu.2022.104753] [PMID: 36168319]
[12]
Kingma TJ, Hoch V, Johnson C, Chaudhry B. Avascular necrosis of the hip: A post COVID-19 sequela. Cureus 2022; 14(10): e29976.
[http://dx.doi.org/10.7759/cureus.29976] [PMID: 36381920]
[http://dx.doi.org/10.7759/cureus.29976] [PMID: 36381920]
[13]
Jyothiprasanth M, Jithin CR, Vincent A, Thomas AK, Pratheesh CB, Sarang P. A case series on COVID-19 infection and avascular necrosis of hip. J Orthop Res 2023; 2(1): 100104.
[14]
Curran CS, Kopp JB. RAGE pathway activation and function in chronic kidney disease and COVID-19. Front Med 2022; 9: 970423.
[http://dx.doi.org/10.3389/fmed.2022.970423] [PMID: 36017003]
[http://dx.doi.org/10.3389/fmed.2022.970423] [PMID: 36017003]
[15]
Huang C, Huang L, Wang Y, et al. RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 2021; 397(10270): 220-32.
[http://dx.doi.org/10.1016/S0140-6736(20)32656-8] [PMID: 33428867]
[http://dx.doi.org/10.1016/S0140-6736(20)32656-8] [PMID: 33428867]
[16]
Jing H, Wu X, Xiang M, Liu L, Novakovic VA, Shi J. Pathophysiological mechanisms of thrombosis in acute and long COVID-19. Front Immunol 2022; 13: 992384.
[http://dx.doi.org/10.3389/fimmu.2022.992384] [PMID: 36466841]
[http://dx.doi.org/10.3389/fimmu.2022.992384] [PMID: 36466841]
[17]
Zanini G, Selleri V, Roncati L, et al. Vascular “Long COVID”: A new vessel disease? Angiology 2023.
[http://dx.doi.org/10.1177/00033197231153204] [PMID: 36652923]
[http://dx.doi.org/10.1177/00033197231153204] [PMID: 36652923]
[18]
Pasini E, Corsetti G, Romano C, et al. Serum metabolic profile in patients with long-COVID (PASC) syndrome: Clinical implications. Front Med 2021; 8: 714426.
[http://dx.doi.org/10.3389/fmed.2021.714426] [PMID: 34368201]
[http://dx.doi.org/10.3389/fmed.2021.714426] [PMID: 34368201]
[19]
Magdy R, Eid RA, Fathy W, et al. Characteristics and risk factors of persistent neuropathic pain in recovered COVID-19 patients. Pain Med 2022; 23(4): 774-81.
[http://dx.doi.org/10.1093/pm/pnab341] [PMID: 34931670]
[http://dx.doi.org/10.1093/pm/pnab341] [PMID: 34931670]
[20]
Ali M, Abdullah F, Naveed A, Ahmed S, Khan A, Hasan A. Role of circulatory miRNA-21 and associated signaling pathways in the pathogenesis of pulmonary fibrosis among individuals recovered after COVID-19 infection. Human Gene 2022; 34: 201093.
[21]
Colarusso C, Maglio A, Terlizzi M, et al. Post-COVID-19 patients who develop lung fibrotic-like changes have lower circulating levels of IFN-β but higher levels of IL-1α and TGF-β. Biomedicines 2021; 9(12): 1931.
[http://dx.doi.org/10.3390/biomedicines9121931] [PMID: 34944747]
[http://dx.doi.org/10.3390/biomedicines9121931] [PMID: 34944747]
[22]
Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D. Biomarkers in long COVID-19: A systematic review. Front Med 2023; 10: 1085988.
[http://dx.doi.org/10.3389/fmed.2023.1085988] [PMID: 36744129]
[http://dx.doi.org/10.3389/fmed.2023.1085988] [PMID: 36744129]
[23]
Chowdhury ATM, Karim MR, Ali MA, Islam J, Li Y, He S. Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients : A prospective multicenter cross-sectional study. Front Med 2021; 8: 663670.
[http://dx.doi.org/10.3389/fmed.2021.663670] [PMID: 34490284]
[http://dx.doi.org/10.3389/fmed.2021.663670] [PMID: 34490284]
